Tianpei Guan
- Hepatology top 10%
- Hepatocellular Carcinoma Treatment and Prognosis 5
- Reproductive Medicine top 10%
- Ovarian cancer diagnosis and treatment 2
-
- Intraperitoneal and Appendiceal Malignancies 4
-
- Radiomics and Machine Learning in Medical Imaging 3
- MRI in cancer diagnosis 2
-
- Cancer-related gene regulation 3
- Epigenetics and DNA Methylation 2
-
- Pancreatic and Hepatic Oncology Research 2
- Partner nations
- ChinaUnited States
In The Last Decade
Tianpei Guan
20 papers receiving 370 citations
Peers
Comparison fields: 5 of 68
- Hepatology 73
- Reproductive Medicine 50
- Cancer Research 40
- Surgery 112
- Biomaterials 33
Countries citing papers authored by Tianpei Guan
This map shows the geographic impact of Tianpei Guan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tianpei Guan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tianpei Guan more than expected).
Fields of papers citing papers by Tianpei Guan
This network shows the impact of papers produced by Tianpei Guan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tianpei Guan. The network helps show where Tianpei Guan may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Tianpei Guan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 12 | |
| 2 | 2023 | 7 | |
| 3 | 2022 | 2 | |
| 4 | 2022 | 11 | |
| 5 | 2021 | 22 | |
| 6 | 2021 | 8 | |
| 7 | 2021 | 12 | |
| 8 | 2021 | 10 | |
| 9 | 2020 | 16 | |
| 10 | 2020 | 59 | |
| 11 | 2019 | 4 | |
| 12 | 2018 | 62 | |
| 13 | 2017 | 11 | |
| 14 | 2017 | 51 | |
| 15 | 2016 | 24 | |
| 16 | [Expression of aldo-keto reductase family 1 member B10 in gastric cancer tissues and its clinical significance]. | 2013 | 3 |
| 17 | 2013 | 12 | |
| 18 | 2013 | 11 | |
| 19 | 2012 | 35 | |
| 20 | 2010 | 3 |
About Tianpei Guan
Tianpei Guan is a scholar working on Hepatology, Reproductive Medicine and Radiology, Nuclear Medicine and Imaging, having authored 20 papers that have together received 375 indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (5 papers), Intraperitoneal and Appendiceal Malignancies (4 papers), Radiomics and Machine Learning in Medical Imaging (3 papers), Cancer-related gene regulation (3 papers), MRI in cancer diagnosis (2 papers), Epigenetics and DNA Methylation (2 papers), Ovarian cancer diagnosis and treatment (2 papers) and Pancreatic and Hepatic Oncology Research (2 papers). The work is most often cited by research in Hepatology (73 citations), Reproductive Medicine (50 citations) and Cancer Research (40 citations). Tianpei Guan has collaborated with scholars based in China and United States. Frequent co-authors include Kun Wang, Wenting Shang, Hongsheng Tang, Shuzhong Cui, Chihua Fang, Jie Tian, Xin Yang, Hui Li, Jie Tian and Ting Ai. Their work appears in journals such as PLoS ONE, Biomaterials and ACS Applied Materials & Interfaces.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.